Measles Vaccine in India Trends and Forecast
The future of the measles vaccine market in India looks promising, with opportunities in the hospital, vaccination center, and community clinic markets. The global measles vaccine market is expected to grow with a CAGR of 5.8% from 2025 to 2031. The measles vaccine market in India is also forecasted to witness strong growth over the forecast period. The major drivers for this market are the growing incidence of measles, expansion in immunization programs, and continuous development of new vaccines.
• Lucintel forecasts that, within the application category, the pediatric population segment is expected to witness the highest growth over the forecast period due to the rising use of the measles vaccination among these people, owing to its increased efficacy.
Emerging Trends in the Measles Vaccine Market in India
The measles vaccine market in India is experiencing a significant transformation driven by various factors, including government initiatives, technological advancements, and changing public perceptions. These developments are shaping the future landscape of immunization programs and vaccine manufacturing. As India aims to eliminate measles, understanding emerging trends is crucial for stakeholders to adapt strategies and improve coverage. The market is witnessing innovations in vaccine delivery, increased private sector participation, and heightened awareness campaigns. These trends collectively influence vaccine accessibility, affordability, and acceptance, ultimately impacting public health outcomes.
• Increasing government initiatives: The Indian government is intensifying efforts to eliminate measles through nationwide immunization campaigns, policy reforms, and funding. This trend boosts vaccine coverage and encourages private sector involvement, creating a more robust market. It also fosters partnerships with international organizations, enhancing resource mobilization and technical support.
• Technological advancements in vaccine development: Innovations such as thermostable vaccines and combination vaccines are emerging, improving efficacy and storage. These advancements reduce logistical challenges, expand reach in remote areas, and enhance overall immunization rates, positively impacting market growth.
• Rise of private sector participation: Private healthcare providers are increasingly involved in vaccine distribution and administration. This diversification increases access points, accelerates vaccination rates, and stimulates market competition, leading to better pricing and quality.
• Increased awareness and demand: Public health campaigns and media outreach are raising awareness about measles risks and vaccine benefits. This heightened demand encourages manufacturers to innovate and expand production, ensuring supply meets rising needs.
• Focus on rural and underserved areas: Strategies targeting rural populations are gaining momentum, including mobile clinics and community outreach programs. These efforts improve vaccine coverage in underserved regions, expanding market reach and reducing disease prevalence.
These emerging trends are collectively reshaping the measles vaccine market in India by enhancing accessibility, affordability, and acceptance. They foster innovation, increase private sector engagement, and focus on underserved populations, leading to a more inclusive and effective immunization landscape. As a result, India is better positioned to achieve its measles elimination goals and improve public health outcomes.
Recent Developments in the Measles Vaccine Market in India
The measles vaccine market in India is experiencing significant growth driven by government initiatives, increased awareness, and the need to eliminate measles. Recent developments reflect efforts to improve vaccine coverage, introduce new formulations, and strengthen supply chains. These changes aim to reduce measles incidence and enhance public health outcomes across the country. The market dynamics are also influenced by international collaborations and technological advancements, making India a key player in global measles vaccination efforts. As the country progresses towards measles elimination, these developments are shaping a more robust and accessible vaccine market.
• Expansion of Immunization Programs: The Indian government has intensified its immunization campaigns, aiming to reach remote and underserved populations. This expansion increases vaccine coverage, reduces measles cases, and boosts demand for vaccines. It also encourages private sector participation, fostering market growth and innovation.
• Introduction of New Vaccine Formulations: New measles vaccine formulations, including combination vaccines, are being introduced to improve compliance and coverage. These innovations simplify immunization schedules and reduce the number of injections, increasing acceptance among parents and healthcare providers. The availability of advanced formulations enhances market competitiveness and broadens product portfolios.
• Strengthening Supply Chain Infrastructure: Investments in cold chain and logistics infrastructure ensure vaccine potency and availability across India. Improved supply chains reduce wastage and stockouts, ensuring consistent vaccine access. This development supports increased vaccination rates and market stability.
• Public-Private Partnerships and Collaborations: Collaborations between government agencies, NGOs, and pharmaceutical companies facilitate vaccine distribution and awareness campaigns. These partnerships help in resource mobilization, capacity building, and expanding outreach, thereby accelerating market growth and coverage.
• Adoption of Digital Technologies: Digital tools for tracking immunization coverage, managing inventories, and monitoring adverse events enhance efficiency and transparency. These technologies improve data accuracy, facilitate targeted interventions, and support policy decisions, ultimately strengthening the measles vaccine market.
These recent developments are collectively transforming the measles vaccine market in India by increasing coverage, improving vaccine formulations, and strengthening infrastructure. They foster a more efficient, accessible, and sustainable market environment, contributing to Indian goal of measles elimination. The ongoing innovations and collaborations are expected to sustain growth and ensure better health outcomes for the population.
Strategic Growth Opportunities for Measles Vaccine Market in India
The measles vaccine market in India is experiencing significant growth driven by increasing awareness, government initiatives, and the need to eradicate measles. As the country aims to improve immunization coverage, various applications of the vaccine are emerging as key growth drivers. These opportunities are transforming the landscape, making vaccines more accessible and affordable. The expansion of vaccination programs and technological advancements is further fueling market development. Understanding these growth opportunities is essential for stakeholders to capitalize on emerging trends and enhance public health outcomes.
• Expansion of immunization programs: The government intensified efforts to include measles vaccines in national immunization schedules are broadening reach, reducing disease incidence, and increasing demand. This expansion ensures wider coverage, especially in rural and underserved areas, leading to a healthier population and a more robust market.
• Introduction of combination vaccines: Combining measles with other vaccines simplifies immunization schedules, improves compliance, and reduces costs. This innovation enhances vaccine acceptance among parents and caregivers, boosting overall vaccination rates and market growth.
• Development of thermostable vaccines: Creating heat-stable vaccines that do not require cold chain storage addresses logistical challenges in remote regions. This advancement facilitates wider distribution, decreases wastage, and ensures vaccine efficacy, thereby expanding market reach.
• Adoption of digital health platforms: Utilizing digital tools for tracking immunization coverage and reminders increases vaccination adherence. These platforms improve data accuracy, streamline logistics, and support targeted campaigns, ultimately driving demand for measles vaccines.
• Public-private partnerships and funding: Collaborations between government agencies, NGOs, and private companies are increasing resource availability for vaccination programs. Enhanced funding and strategic partnerships accelerate vaccine deployment, improve infrastructure, and foster innovation, contributing to sustained market growth.
These strategic growth opportunities are significantly impacting the measles vaccine market in India by expanding access, improving efficiency, and fostering innovation. They are contributing to higher immunization rates, reducing disease burden, and supporting the country goal of measles elimination. As these developments continue, the market is poised for robust growth, driven by technological advancements, policy support, and increased public awareness.
Measles Vaccine Market in India Driver and Challenges
The major drivers and challenges impacting the measles vaccine market in India encompass various technological, economic, and regulatory factors. These elements significantly influence market growth, accessibility, and innovation, shaping the overall landscape of immunization efforts across the country.
The factors responsible for driving the measles vaccine market in India include:-
• Increasing government initiatives and immunization programs: The Indian government has launched extensive immunization campaigns, such as the Universal Immunization Program (UIP), aiming to reduce measles incidence. These initiatives boost vaccine demand, improve coverage, and foster public awareness. The government focus on eliminating vaccine-preventable diseases creates a conducive environment for market growth. Additionally, partnerships with international organizations enhance resource allocation and distribution networks, further expanding vaccine reach.
• Rising prevalence of measles and outbreaks: Despite vaccination efforts, measles outbreaks continue to occur due to gaps in coverage and vaccine hesitancy. The increasing prevalence underscores the need for more effective immunization strategies, driving demand for improved vaccines and booster doses. This situation compels stakeholders to invest in better vaccine formulations and distribution channels to control outbreaks.
• Technological advancements in vaccine development: Innovations such as combination vaccines and thermostable formulations improve efficacy and storage, making immunization more accessible, especially in remote areas. Advances in biotechnology enable faster development of new vaccines, addressing emerging strains and enhancing overall immunization programs. These technological improvements reduce costs and increase acceptance among populations.
• Growing awareness and health consciousness: Increased awareness about the importance of vaccines and disease prevention encourages higher vaccination rates. Public health campaigns and education initiatives inform communities about measles risks and vaccine benefits, leading to greater acceptance and demand. This trend supports market expansion by fostering trust and reducing vaccine hesitancy.
The challenges in the measles vaccine market in India are:
• Vaccine hesitancy and misinformation: Misinformation about vaccine safety and efficacy hampers immunization efforts. Cultural beliefs, misconceptions, and distrust in healthcare systems lead to reluctance or refusal to vaccinate, creating gaps in herd immunity. Overcoming these barriers requires targeted education and community engagement, which can be resource-intensive.
• Supply chain and cold chain infrastructure limitations: Maintaining the integrity of vaccines requires robust cold chain systems. In India, inadequate infrastructure in rural and remote areas hampers timely distribution and storage, leading to vaccine wastage and reduced coverage. Strengthening logistics and infrastructure is essential but challenging due to logistical and financial constraints.
• Regulatory and pricing challenges: Ensuring timely approval of new vaccines and managing pricing strategies to impact market growth. High costs of advanced vaccines can limit accessibility for low-income populations. Regulatory delays and pricing disputes can slow down the introduction of innovative vaccines, affecting overall immunization coverage.
In summary, the measles vaccine market in India is shaped by significant drivers such as government initiatives, technological progress, and increasing awareness, which promote growth and innovation. However, challenges like vaccine hesitancy, infrastructure limitations, and regulatory hurdles pose obstacles to achieving comprehensive immunization coverage. Addressing these issues through strategic interventions is crucial for enhancing vaccine accessibility and disease control, ultimately fostering a healthier population.
List of Measles Vaccine Market in India Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, measles vaccine companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the measles vaccine companies profiled in this report include:
• Company 1
• Company 2
• Company 3
• Company 4
• Company 5
• Company 6
• Company 7
• Company 8
• Company 9
• Company 10
Measles Vaccine Market in India by Segment
The study includes a forecast for the measles vaccine market in India by type, application, and end use.
Measles Vaccine Market in India by Type [Analysis by Value from 2019 to 2031]:
• Mumps Measles Rubella Vaccine
• Live MMR-II
Measles Vaccine Market in India by Application [Analysis by Value from 2019 to 2031]:
• Pediatric Population
• Adolescent Population
• Adult Population
Measles Vaccine Market in India by End Use [Analysis by Value from 2019 to 2031]:
• Hospitals
• Vaccination Centers
• Community Clinics
Features of the Measles Vaccine Market in India
Market Size Estimates: Measles vaccine in India market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends and forecasts by various segments.
Segmentation Analysis: Measles vaccine in India market size by type, application, and end use in terms of value ($B).
Growth Opportunities: Analysis of growth opportunities in different types, applications, and end uses for the measles vaccine in India.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the measles vaccine in India.
Analysis of competitive intensity of the industry based on Porter Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q.1 What are the major drivers influencing the growth of the measles vaccine market in India?
Answer: The major drivers for this market are growing incidence of measles, expansion in immunization programs, and continuous development of new vaccines.
Q2. What are the major segments for measles vaccine market in India?
Answer: The future of the measles vaccine market in India looks promising, with opportunities in the hospital, vaccination center, and community clinic markets.
Q3. Which measles vaccine market segment in India will be the largest in future?
Answer: Lucintel forecasts that pediatric population segment is expected to witness the highest growth over the forecast period due to rising use of the measles vaccination among these people, owing to its increased efficacy.
Q4. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 10 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the measles vaccine market in India by type (mumps measles rubella vaccine and live mmr-II), application (pediatric population, adolescent population, and adult population), and end use (hospitals, vaccination centers, and community clinics)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.4. What are the business risks and competitive threats in this market?
Q.5. What are the emerging trends in this market and the reasons behind them?
Q.6. What are some of the changing demands of customers in the market?
Q.7. What are the new developments in the market? Which companies are leading these developments?
Q.8. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.9. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.10. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Measles Vaccine Market in India, Measles Vaccine Market in India Size, Measles Vaccine Market in India Growth, Measles Vaccine Market in India Analysis, Measles Vaccine Market in India Report, Measles Vaccine Market in India Share, Measles Vaccine Market in India Trends, Measles Vaccine Market in India Forecast, Measles Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.